Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3527) 3527
Book Chapter (100) 100
Newsletter (79) 79
Newspaper Article (8) 8
Magazine Article (7) 7
Book / eBook (5) 5
Conference Proceeding (2) 2
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2759) 2759
science & technology (2536) 2536
life sciences & biomedicine (2452) 2452
aspergillosis (1583) 1583
male (1417) 1417
female (1362) 1362
infectious diseases (1202) 1202
middle aged (1077) 1077
adult (1058) 1058
aspergillosis - epidemiology (937) 937
mycoses (886) 886
biological and medical sciences (884) 884
antifungal agents - therapeutic use (846) 846
microbiology (813) 813
medical sciences (773) 773
aged (722) 722
risk factors (658) 658
aspergillosis - microbiology (652) 652
aspergillus (610) 610
aspergillosis - drug therapy (599) 599
adolescent (576) 576
mycology (576) 576
aspergillosis - diagnosis (539) 539
retrospective studies (517) 517
antifungal agents (449) 449
health aspects (448) 448
child (446) 446
epidemiology (443) 443
immunology (433) 433
transplantation (405) 405
immunocompromised host (387) 387
invasive aspergillosis (387) 387
aspergillus - isolation & purification (386) 386
fungal infections (381) 381
animals (375) 375
fungi (373) 373
human mycoses (368) 368
aspergillus fumigatus (361) 361
incidence (335) 335
infections (326) 326
diagnosis (323) 323
mortality (320) 320
young adult (315) 315
aspergillus fumigatus - isolation & purification (306) 306
research (301) 301
aspergillosis - etiology (300) 300
voriconazole (297) 297
care and treatment (296) 296
child, preschool (289) 289
treatment outcome (288) 288
mycoses - epidemiology (285) 285
hematology (277) 277
antifungal agents - pharmacology (248) 248
patients (245) 245
candidiasis (236) 236
aged, 80 and over (232) 232
pharmacology & pharmacy (229) 229
dermatology (225) 225
aspergillosis - prevention & control (222) 222
abridged index medicus (214) 214
pulmonary aspergillosis (212) 212
analysis (210) 210
general & internal medicine (208) 208
aspergillosis - complications (207) 207
respiratory system (204) 204
aspergillus fumigatus - genetics (199) 199
miscellaneous mycoses (199) 199
fundamental and applied biological sciences. psychology (197) 197
antifungal agents - administration & dosage (196) 196
infant (194) 194
prevalence (194) 194
candidiasis - epidemiology (193) 193
amphotericin b - therapeutic use (186) 186
neutropenia (184) 184
prospective studies (184) 184
medical research (182) 182
amphotericin b (176) 176
lung diseases, fungal - epidemiology (173) 173
aspergillosis - pathology (171) 171
mycoses - drug therapy (171) 171
triazoles - therapeutic use (170) 170
surgery (168) 168
pharmacology. drug treatments (165) 165
aspergillosis - immunology (164) 164
internal medicine (160) 160
medicine, experimental (159) 159
research article (159) 159
allergic bronchopulmonary aspergillosis (156) 156
aspergillus fumigatus - drug effects (156) 156
medicine (156) 156
aspergillosis - mortality (155) 155
infection (155) 155
medicine & public health (155) 155
mycoses - microbiology (152) 152
oncology (149) 149
life sciences (147) 147
microbial sensitivity tests (147) 147
prognosis (143) 143
candidiasis - drug therapy (142) 142
cross infection - epidemiology (142) 142
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3505) 3505
German (116) 116
French (79) 79
Spanish (69) 69
Japanese (24) 24
Russian (14) 14
Portuguese (13) 13
Polish (9) 9
Chinese (8) 8
Turkish (8) 8
Italian (6) 6
Dutch (4) 4
Czech (3) 3
Finnish (3) 3
Hungarian (2) 2
Norwegian (2) 2
Swedish (2) 2
Bulgarian (1) 1
Danish (1) 1
Korean (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


81. Full Text Epidemiology and clinical characteristics of invasive mould infections: A multicenter, retrospective analysis in five Asian countries
by Rotjanapan, P and Chen, Y C and Chakrabarti, A and Li, R Y and Rudramurthy, S M and Yu, J and Kung, H C and Watcharananan, S and Tan, A L and Saffari, S E and Tan, B H
Medical mycology (Oxford), ISSN 1369-3786, 02/2018, Volume 56, Issue 2, pp. 186 - 196
invasive mould disease | invasive aspergillosis | diabetes mellitus | Veterinary Sciences | Infectious Diseases | Life Sciences & Biomedicine | Mycology | Science & Technology | Humans | Middle Aged | Child, Preschool | Male | Lung - diagnostic imaging | Antifungal Agents - therapeutic use | Incidence | Young Adult | Invasive Fungal Infections - drug therapy | Fungi - physiology | Aged, 80 and over | Adult | Female | Retrospective Studies | Child | Invasive Fungal Infections - epidemiology | Risk Factors | Treatment Outcome | Invasive Fungal Infections - diagnosis | Asia - epidemiology | Adolescent | Aged | Aspergillus - physiology | Amphotericin B - therapeutic use | Invasive Fungal Infections - microbiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
82. Full Text Burden of serious fungal diseases in Hungary
by Sinkó, János and Sulyok, Mihály and Denning, David W
Mycoses, ISSN 0933-7407, 10/2015, Volume 58, Issue S5, pp. 29 - 33
epidemiology | invasive fungal disease | candidiasis | Aspergillosis | Candidiasis | Epidemiology | Invasive fungal disease | Life Sciences & Biomedicine | Dermatology | Mycology | Science & Technology | Allergens | Mycoses - epidemiology | Candidiasis, Vulvovaginal - epidemiology | Prevalence | Aspergillosis, Allergic Bronchopulmonary - microbiology | Pulmonary Disease, Chronic Obstructive - microbiology | Humans | Middle Aged | Cost of Illness | Mycoses - microbiology | Pulmonary Disease, Chronic Obstructive - epidemiology | Incidence | Young Adult | Adult | Female | Asthma - etiology | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Asthma - epidemiology | Candidemia - microbiology | Asthma - microbiology | Hungary - epidemiology | Candidemia - epidemiology | Pulmonary Disease, Chronic Obstructive - complications | Dermatomycoses - epidemiology | Adolescent | Quality of Life | Candidiasis, Vulvovaginal - microbiology | Dermatomycoses - microbiology | Mycoses | Lung diseases, Obstructive | Health aspects | Hematopoietic stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
83. Full Text Epidemiology of Emerging Fungal Infections in ICU
by Chakrabarti, Arunaloke and Sharma, Megha
Current fungal infection reports, ISSN 1936-3761, 3/2019, Volume 13, Issue 1, pp. 1 - 10
Candida auris | Pneumology/Respiratory System | Yeast | Medicine & Public Health | Occupational Medicine/Industrial Medicine | Antifungal resistance | Infectious Diseases | Internal Medicine | Outbreaks | Epidemiology | Mycelium | Tropical Medicine | Drug resistance in microorganisms | Antifungal agents | Mycoses | Disease susceptibility | Cross infection | Nosocomial infections | Health aspects | Pathogens | Candidiasis | Intensive care | Risk groups | Multidrug resistance | Mycelia | Fungal infections | Geographical variations | Drug resistance | Risk factors | Rare species | Fungi | Intensive care units | Aspergillosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
84. Fungal co-infection in COVID-19 patients: Should we be concerned?
by Pemán, Javier and Ruiz-Gaitán, Alba and García-Vidal, Carolina and Salavert, Miguel and Ramírez, Paula and Puchades, Francesc and García-Hita, Marta and Alastruey-Izquierdo, Ana and Quindós, Guillermo
Revista iberoamericana de micologia, 04/2020, Volume 37, Issue 2, p. 41
Pandemics | Interleukins - blood | Candidiasis, Invasive - epidemiology | Humans | Tumor Necrosis Factor-alpha - blood | Coinfection - epidemiology | Pneumonia, Viral - blood | CD8-Positive T-Lymphocytes | COVID-19 | SARS-CoV-2 | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Pneumonia, Pneumocystis - epidemiology | Spain - epidemiology | Coronavirus Infections - blood | Betacoronavirus | CD4-Positive T-Lymphocytes | Interferon-gamma - blood | Invasive Pulmonary Aspergillosis - epidemiology
Journal Article
Details down arrow
85. Epidemiology of invasive mycoses: A landscape in continuous change
by Quindós, Guillermo
Revista iberoamericana de micología, ISSN 1130-1406, 10/2018, Volume 35, Issue 4, pp. 171 - 178
Candida auris | Candidiasis | Aspergillosis | Antifungal resistance | Mycoses | Aspergillus fumigatus | Epidemiology | Life Sciences & Biomedicine | Mycology | Science & Technology
Journal Article
Details down arrow
86. Full Text Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study
by Mariette, Clara and Tavernier, Emmanuelle and Hocquet, Didier and Huynh, Anne and Isnard, Françoise and Legrand, Faezeh and Lhéritier, Véronique and Raffoux, Emmanuel and Dombret, Hervé and Ifrah, Norbert and Cahn, Jean-Yves and Thiébaut, Anne
Leukemia & lymphoma, ISSN 1042-8194, 03/2017, Volume 58, Issue 3, pp. 586 - 593
invasive candidiasis | invasive aspergillosis | Acute lymphoblastic leukemia | invasive fungal infections | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Humans | Middle Aged | Aspergillosis - diagnosis | Male | Aspergillosis - epidemiology | Antifungal Agents - therapeutic use | Young Adult | Candidiasis, Invasive - diagnosis | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Clinical Trials, Phase III as Topic | Aspergillosis - etiology | Time Factors | Invasive Fungal Infections - drug therapy | Candidiasis, Invasive - drug therapy | Adult | Female | Retrospective Studies | Aspergillosis - drug therapy | Candidiasis, Invasive - etiology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications | France - epidemiology | Invasive Fungal Infections - epidemiology | Candidiasis, Invasive - epidemiology | Invasive Fungal Infections - diagnosis | Induction Chemotherapy - adverse effects | Randomized Controlled Trials as Topic | Adolescent | Invasive Fungal Infections - etiology | Index Medicus | Life Sciences | Microbiology and Parasitology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
87. Full Text Pulmonary aspergillosis: A clinical review
by Kousha, M and Tadi, R and Soubani, A.O
European respiratory review, ISSN 0905-9180, 09/2011, Volume 20, Issue 121, pp. 156 - 174
Diagnosis | Management | Pulmonary | Risk factors | Aspergillosis | Invasive Pulmonary Aspergillosis - drug therapy | Predictive Value of Tests | Pulmonary Aspergillosis - drug therapy | Aspergillosis, Allergic Bronchopulmonary - microbiology | Risk Assessment | Humans | Risk Factors | Treatment Outcome | Pulmonary Aspergillosis - diagnosis | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Pulmonary Aspergillosis - microbiology | Invasive Pulmonary Aspergillosis - diagnosis | Antifungal Agents - therapeutic use | Pulmonary Aspergillosis - epidemiology | Invasive Pulmonary Aspergillosis - microbiology | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Invasive Pulmonary Aspergillosis - epidemiology | Hypersensitivity | Lung diseases | Mortality | Antifungal agents | Aspergilloma | Immunodeficiency | Chronic infection | Cystic fibrosis | Allergic diseases | Inflammation | Malignancy | Immune status | Allergic bronchopulmonary aspergillosis | Epidemiology | Asthma | Atopy | Cavities | Reviews | Chronic obstructive pulmonary disease | Index Medicus | diagnosis | pulmonary | risk factors | management
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
88. Full Text Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
by Illa, Isabel and Kissel, John T and Nowak, Richard J and Wang, Jing Jing and Fujita, Kenji P and Garcia, Alejandra Dalila and de Koning, Kathy and Stevens, Olivier and Pozo, Marina and Souza Duca, Luciana and Guerreiro, Alexandre and Carrara, Fernanda and Siddiqi, Zaeem and Kurkova, Barbora and Pitha, Jiri and Wolfova, Marcela and Pedersen, Jane and Oksaranta, Olli and Jakab, Gedeonne and Antonini, Giovanni and Di Pasquale, Antonella and Costabile, Teresa and Marsili, Angela and Bonanno, Silvia and Camera, Giorgia and Pasanisi, Maria and Gabriele, Maria and Matsushita, Takuya and Kikutake, Keiko and Nakamura, Yumiko and Samukawa, Makoto and Mitazaki, Teiichiro and Yoshimura, Shunsuke and Tsurumaru, Masako and Makamori, Masayuki and Takahashi, Masanori and Hasuike, Tomoya and Kobayashi, Hisako and Osakada, Kaori and Imai, Tomihiro and Tsuda, Emiko and Murahara, Takashi and Suzuki, Shuichiro and Uwasa, Kaori and Min, Ju-Hong and Koh, Da Yoon and Kwon, JuYoung and Hwang, Ji Ye and Kim, Miri and Jung, JinWoo and Shin, Ha Young and Shin, Miju and Lazaro, Ana and Diez Tejedor, Exuperio and Salvado, Maria and Mazuela, Gonzalo and Diaz-Manera, Jordi and Piehl, Fredrik and Hietala, Albert and Sengun, Ihsan and Bekircan‐Kurt, Can Ebru and Orsel, Gulsah and Semiz, Cansu and Veske, Adife and Sokratous, Giannis and Sohail, Faisal and Arndt, Heike and Amato, Anthony and Salajegheh, Mohammed and Patrick, Kara and Bravver, Elena and Cunningham, Scott and Schommer, Clara and Carnes, Donna and Bodkin, Cynthia and Carter, Cynthia and Jeffery, Dennis and Chelnick, Sharon and Marburger, Tessa and Gilchrist, James and Andoin, Angela and Seelback, Jenna and Bhavaraju-Sanka, Ratna and Alsharabati, Mohammad and Lu, Liang and Rosenfeld, Jeffrey and Pulley, Michael and Shah, Jaimin and Gutmann, Ludwig and Pasnoor, Mamatha and Jenci, Nicole and Locheke, Jerry and Fondaw, Alex and Sharma, Khema and Steele, Julie and Chopra, Manisha and Katzin, Lara and Waheed, Waqar and Distad, Jane and Robeson, Kimberly and REGAIN Study Grp and Regain Study Group and for the Regain Study Group
Muscle & nerve, ISSN 0148-639X, 07/2019, Volume 60, Issue 1, pp. 14 - 24
MGC | myasthenia gravis | MG‐ADL | eculizumab | QMG | MG‐QOL15 | MG-ADL | MG-QOL15 | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Meningococcal Infections - epidemiology | Meningococcal Vaccines - therapeutic use | Humans | Middle Aged | Male | Aspergillosis - epidemiology | Activities of Daily Living | Aspergillosis - etiology | Heart Diseases - epidemiology | Meningococcal Infections - etiology | Adult | Female | Heart Diseases - chemically induced | Injection Site Reaction - epidemiology | Muscle Strength | Angioedema - epidemiology | Antibodies, Monoclonal, Humanized - therapeutic use | Injection Site Reaction - etiology | Meningococcal Infections - prevention & control | Treatment Outcome | Disease Progression | Myasthenia Gravis - physiopathology | Complement Inactivating Agents - therapeutic use | Quality of Life | Angioedema - chemically induced | Longitudinal Studies | Myasthenia Gravis - drug therapy | Myasthenia gravis | Effectiveness | Activities of daily living | Antibodies | Neuromuscular junctions | Remission | Myasthenia | Pharmacology | Safety | Muscular strength | Quality of life | Index Medicus | Clinical | Clinical s
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
89. Full Text Estimated burden of fungal infections in Sweden
by Özenci, Volkan and Klingspor, Lena and Ullberg, Måns and Chryssanthou, Erja and Denning, David W and Kondori, Nahid and Institute of Biomedicine, Department of Infectious Medicine and Sahlgrenska akademin and Institutionen för biomedicin, avdelningen för infektionssjukdomar and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
Mycoses, ISSN 0933-7407, 11/2019, Volume 62, Issue 11, pp. 1043 - 1048
epidemiology | fungal infections | Life Sciences & Biomedicine | Dermatology | Mycology | Science & Technology | Mycoses - epidemiology | Prevalence | Humans | Middle Aged | Child, Preschool | Cost of Illness | Mycoses - microbiology | Infant | Male | Dermatomycoses - epidemiology | Sweden - epidemiology | Incidence | Vulvovaginitis - microbiology | Respiratory Tract Infections - microbiology | Vulvovaginitis - epidemiology | Adolescent | Female | Aged | Dermatomycoses - microbiology | Respiratory Tract Infections - epidemiology | Child | Infant, Newborn | Medical research | Antifungal agents | Mycoses | Medicine, Experimental | Health aspects | Epidemiology | Prevalence studies (Epidemiology) | Vulvovaginitis | Tuberculosis | Sarcoidosis | Recurrent infection | Aspergillosis | Fungal infections | Candidemia | Allergic bronchopulmonary aspergillosis | Morbidity | Asthma | Index Medicus | disease | Dermatologi och venereologi | Dermatology and Venereal Diseases | oropharyngeal | global burden | prevalence | chronic pulmonary aspergillosis | candidiasis | epidemiologic trends | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
90. Full Text Epidemiology of invasive fungal infections in neonates and children
by Steinbach, W.J
Clinical microbiology and infection, ISSN 1198-743X, 09/2010, Volume 16, Issue 9, pp. 1321 - 1327
fungal infection | Antifungal | candidiasis | review | aspergillosis | paediatric | Paediatric | Candidiasis | Review | Fungal infection | Aspergillosis | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Mycoses - epidemiology | Mycoses - prevention & control | Antifungal Agents - adverse effects | Opportunistic Infections - epidemiology | Humans | Child, Preschool | Infant | Opportunistic Infections - mortality | Treatment Outcome | Opportunistic Infections - prevention & control | Antifungal Agents - therapeutic use | Opportunistic Infections - diagnosis | Adolescent | Mycoses - diagnosis | Mycoses - mortality | Child | Infant, Newborn | Infants (Newborn) | Analysis | Antifungal agents | Mycoses | Children | Epidemiology | Risk factors | Diseases | Fungal infections | Medical treatment | Mortality | Index Medicus | Infection | Neonates | Pediatrics | Reviews | Data processing | Morbidity
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
91. Full Text Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources
by Tavakoli, Mahin and Rivero‐Menendez, Olga and Abastabar, Mahdi and Hedayati, Mohammad T and Sabino, Raquel and Siopi, Maria and Zarrinfar, Hossein and Nouripour‐Sisakht, Sadegh and Lee, Henrich and Valadan, Reza and Meletiadis, Joseph and Yazdani Charati, Jamshid and Seyedmousavi, Seyedmojtaba and Alastruey‐Izquierdo, Ana
Mycoses, ISSN 0933-7407, 01/2020, Volume 63, Issue 1, pp. 78 - 88
genetic diversity | Aspergillus nidulans | Aspergillus spinulosporus | β‐tubulin | amphotericin B | antifungal susceptibility | cryptic species | Life Sciences & Biomedicine | Dermatology | Mycology | Science & Technology | Aspergillus fumigatus - drug effects | Aspergillus - classification | Aspergillus nidulans - genetics | Humans | Netherlands - epidemiology | Tubulin - genetics | Phylogeny | Genetic Variation | Microbial Sensitivity Tests | Aspergillosis - etiology | Aspergillus fumigatus - isolation & purification | Portugal - epidemiology | Aspergillus - genetics | Aspergillosis - drug therapy | Antifungal Agents - pharmacology | Aspergillus nidulans - drug effects | Phylogeography | Amphotericin B - pharmacology | Micafungin - pharmacology | Greece - epidemiology | Aspergillus fumigatus - genetics | Azoles - pharmacology | Aspergillus - drug effects | Microsatellite Repeats - genetics | Anidulafungin - pharmacology | Environmental Microbiology | Molecular Epidemiology | Spain - epidemiology | Cross Infection - microbiology | Aspergillus nidulans - isolation & purification | Iran - epidemiology | Azoles | Tubulin | Genotyping | Amphotericin B | Genetic diversity | Micafungin | Posaconazole | Species | Epidemiology | Strains (organisms) | Niches | Itraconazole | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights